Listen: Is 23andMe Trading Your DNA? With Maria Liu from First Health Advisory Solutions

 

23andMe, the genetic testing company, just announced that it will be entering a 4-year partnership with pharmaceutical giant GlaxoSmithKline (GSK) to develop new drugs and therapies.

As part of the partnership, 23andMe will share voluntarily-shared genetic data with the big pharma company. Maria Liu from First Health Advisory Solutions joined us to talk about the security concerns and potential worries that come with companies sharing medical data.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!
Twitter – @HealthMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Latest

Trends and Technology at InfoComm 2021
Don’t Touch This: Trends and Technology at InfoComm 2021
October 22, 2021
  Key Points: The cost in the LED market has dramatically decreased from a manufacturing perspective and a consumer demand perspective, LED's are a lot more attainable. The LED market is expected Read more
Mainstream Modular: The Engineering Specifics of Modular Construction
October 22, 2021
  DCI Engineers, a structural and civil engineering services company based out of Seattle, Washington, since 1988 partnered with Guerdon on several modular construction projects. Troy Bean, Read more
Adjusting the Way We Approach an Injured Worker
Adjusting the Way We Approach an Injured Worker
October 22, 2021
A new term was coined to illustrate those that use their body for work—an industrial athlete. With this new designation comes new ways to think about the healing and recovery process when workers get Read more